Group I p21-activated kinases regulate thyroid cancer cell migration and are overexpressed and activated in thyroid cancer invasion.
p21-activated kinases (PAKs) are a family of serine/threonine kinases that regulate cytoskeletal dynamics and cell motility. PAKs are subdivided into group I (PAKs 1-3) and group II (PAKs 4-6) on the basis of structural and functional characteristics. Based on prior gene expression data that predicted enhanced PAK signaling in the invasive fronts of aggressive papillary thyroid cancers (PTCs), we hypothesized that PAKs functionally regulate thyroid cancer cell motility and are activated in PTC invasive fronts. We examined PAK isoform expression in six human thyroid cancer cell lines (BCPAP, KTC1, TPC1, FTC133, C643, and SW1746) by quantitative reverse transcription-PCR and western blot. All cell lines expressed PAKs 1-4 and PAK6 mRNA and PAKs 1-4 protein; PAK6 protein was variably expressed. Samples from normal and malignant thyroid tissues also expressed PAKs 1-4 and PAK6 mRNA; transfection with the group I (PAKs 1-3) PAK-specific p21 inhibitory domain molecular inhibitor reduced transwell filter migration by ∼50% without altering viability in all cell lines (P<0.05). BCPAP and FTC133 cells were transfected with PAK1, PAK2, or PAK3-specific small interfering RNA (siRNA); only PAK1 siRNA reduced migration significantly for both cell lines. Immunohistochemical analysis of seven invasive PTCs demonstrated an increase in PAK1 and pPAK immunoactivity in the invasive fronts versus the tumor center. In conclusion, PAK isoforms are expressed in human thyroid tissues and cell lines. PAK1 regulates thyroid cancer cell motility, and PAK1 and pPAK levels are increased in PTC invasive fronts. These data implicate PAKs as regulators of thyroid cancer invasion.
McCarty
Samantha K
SK
Divisions of Endocrinology and Oncology Center for Biostatistics, The Ohio State University College of Medicine and Arthur G. James Comprehensive Cancer Center, 1581 Dodd Drive, Columbus, Ohio 43210, USA.
Saji
Motoyasu
M
Zhang
Xiaoli
X
Jarjoura
David
D
Fusco
Alfredo
A
Vasko
Vasyl V
VV
Ringel
Matthew D
MD
D015153:Blotting, Western; D045744:Cell Line, Tumor; D002465:Cell Movement / Q000502:physiology*; D006801:Humans; D007150:Immunohistochemistry; D009361:Neoplasm Invasiveness / Q000235:genetics / Q000473:pathology; D010766:Phosphorylation; D020033:Protein Isoforms / Q000235:genetics / Q000378:metabolism; D012333:RNA, Messenger / Q000235:genetics / Q000378:metabolism; D034741:RNA, Small Interfering; D020133:Reverse Transcriptase Polymerase Chain Reaction; D015398:Signal Transduction; D013961:Thyroid Gland / Q000378:metabolism* / Q000473:pathology; D013964:Thyroid Neoplasms / Q000235:genetics / Q000378:metabolism* / Q000473:pathology; D015854:Up-Regulation; D054462:p21-Activated Kinases / Q000235:genetics / Q000378:metabolism*
D020033:Protein Isoforms; D012333:RNA, Messenger; D034741:RNA, Small Interfering; D054462:p21-Activated Kinases
Oncogene. 2006 May 11;25(20):2931-6
16331248
Proc Natl Acad Sci U S A. 2007 Feb 20;104(8):2803-8
17296934
Cell Cycle. 2004 Jan;3(1):71-4
14657670
Annu Rev Biochem. 2003;72:743-81
12676796
Curr Opin Oncol. 2007 Jan;19(1):11-7
17133106
J Clin Endocrinol Metab. 2005 Oct;90(10):5723-9
16030160
Oncogene. 2007 Mar 15;26(12):1820-8
17001318
Nat Rev Cancer. 2002 Jun;2(6):442-54
12189386
Nat Cell Biol. 2008 Nov;10(11):1356-64
18931661
J Biol Chem. 2000 Apr 21;275(16):12041-50
10766836
Curr Opin Endocrinol Diabetes Obes. 2009 Oct;16(5):361-6
19584719
Virology. 1987 Nov;161(1):62-72
2823470
Biochem J. 2005 Mar 1;386(Pt 2):201-14
15548136
Thyroid. 2007 Jul;17(7):639-46
17696834
Cell Signal. 2009 Dec;21(12):1738-47
19628037
J Clin Invest. 2009 Jun;119(6):1420-8
19487818
Clin Cancer Res. 2004 May 15;10(10):3448-56
15161701
Thyroid. 2009 Dec;19(12):1393-400
20001721
J Biol Chem. 2007 Apr 20;282(16):11836-48
17255101
Cancer Res. 2003 Aug 1;63(15):4561-7
12907632
Int J Biochem Cell Biol. 2002 Jul;34(7):713-7
11950587
Mol Cell Endocrinol. 1996 Aug 9;121(2):143-51
8892315
Nat Neurosci. 2006 Feb;9(2):234-42
16415866
J Cell Physiol. 2002 Nov;193(2):133-44
12384990
Recent Results Cancer Res. 1990;118:48-63
2173080
Oncogene. 2009 Jul 16;28(28):2545-55
19465939
Cancer Metastasis Rev. 2003 Dec;22(4):385-93
12884913
Cancer Res. 2009 Sep 15;69(18):7135-9
19738043
Int J Cancer. 2010 Jul 1;127(1):21-31
19876919
Cancer. 1994 Apr 15;73(8):2206-12
8156527
J Natl Cancer Inst. 2006 May 17;98(10):671-80
16705121
J Biol Chem. 2000 Jun 30;275(26):19693-9
10779525
J Clin Endocrinol Metab. 2008 Nov;93(11):4331-41
18713817
J Biol Chem. 2007 May 25;282(21):15667-78
17392278
Nat Rev Cancer. 2006 Jun;6(6):459-71
16723992
J Biol Chem. 2000 Dec 29;275(52):41201-9
10995762
Methods. 2005 Oct;37(2):203-7
16288885
J Clin Endocrinol Metab. 2000 Aug;85(8):2889-96
10946899
Oncogene. 2009 Jun 25;28(25):2365-9
19421139
Cancer Res. 2001 Aug 15;61(16):6105-11
11507060
J Biol Chem. 2005 Nov 4;280(44):36609-15
16129686
Blood. 2008 Dec 1;112(12):4646-54
18768391
Cancer Res. 2006 Jun 15;66(12):5985-8
16778166